We recently provided evidence that activin was associated with increased expression of CTLA-4, CD25, and PI3K activation in the tumor microenvironment (TME) suggesting that this molecule may be promoting expression of these checkpoint markers through the PI3K pathway22. The gene discussed is INHBE; the disease is neoplasm.